Table 1.
Identification of study population
| ID | Form of leprosy | Reaction | Gender | Age (years) | BI | DG |
|---|---|---|---|---|---|---|
| RE01 | LL | T2R | F | 23 | 4.0 | 0 |
| RE02 | LL | T2R | M | 74 | 4.0 | 2 |
| RE03 | LL | T2R | M | 42 | 4.5 | 1 |
| RE04 | LL | T2R | M | 64 | 2.5 | 2 |
| RE05 | LL | T2R | M | 32 | 2.5 | 1 |
| RE06 | LL | T2R | M | 54 | 4.0 | 1 |
| RE07 | LL | T2R | M | 66 | 3.75 | 0 |
| RE08 | LL | T2R | M | 60 | 1.75 | 2 |
| RE09 | LL | T2R | M | 18 | 3.75 | 2 |
| RE10 | LL | T2R | F | 38 | 5.75 | 1 |
| RE11 | LL | T2R | F | 57 | 4.5 | 1 |
| RE12 | LL | T2R | F | 33 | 3.5 | 0 |
| RE13 | LL | T2R | M | 26 | 3.5 | 0 |
| RE14 | LL | T2R | M | 32 | 4.5 | 1 |
| RE15 | LL | T2R | M | 45 | 2.5 | 0 |
| RE16 | LL | T2R | M | 62 | 4.5 | 0 |
| RE17 | LL | T2R | M | 33 | 4.5 | 1 |
| RE18 | LL | T2R | M | 35 | 4.75 | 1 |
| RE19 | LL | T2R | F | 27 | 5.0 | 1 |
| LP01 | LL | – | M | 26 | 5.0 | 2 |
| LP02 | LL | – | M | 32 | 5.0 | 0 |
| LP03 | LL | – | M | 33 | 4.75 | 0 |
| LP04 | LL | – | M | 39 | 5.0 | 0 |
| LP05 | LL | – | F | 31 | 5.0 | 0 |
| LP06 | LL | – | F | 31 | 4.75 | 0 |
| LP07 | LL | – | M | 32 | 5.75 | 0 |
| LP08 | LL | – | M | 24 | 5.0 | 2 |
| LP09 | LL | – | F | 27 | 5.5 | 1 |
| LP10 | LL | – | M | 38 | 5.5 | 0 |
| LP11 | LL | – | M | 37 | 5.5 | 0 |
| LP12 | LL | – | F | 40 | 5.0 | 1 |
| LP13 | LL | – | M | 65 | 4.75 | 0 |
| LP14 | LL | – | M | 37 | 5.0 | 0 |
| LP15 | LL | – | M | 48 | 5.0 | 0 |
| HV01 | HV | – | M | 22 | – | – |
| HV02 | HV | – | F | 28 | – | – |
| HV03 | HV | – | F | 50 | – | – |
| HV04 | HV | – | F | 23 | – | – |
| HV05 | HV | – | F | 26 | – | – |
| HV06 | HV | – | F | 22 | – | – |
| HV07 | HV | – | F | 40 | – | – |
| HV08 | HV | – | M | 35 | – | – |
| HV09 | HV | – | M | 40 | – | – |
| HV10 | HV | – | M | 45 | – | – |
| HV11 | HV | – | F | 22 | – | – |
| HV12 | HV | – | F | 21 | – | – |
| HV13 | HV | – | F | 27 | – | – |
| HV14 | HV | – | M | 48 | – | – |
| HV15 | HV | – | F | 22 | – | – |
BI = bacteriological index; DG = disability grade; F = female; HV = healthy volunteer; ID = randomized code for each patient or HVs to safeguard their identity; LL = lepromatous leprosy; M = male.